Johns Hopkins startup Neuraly plans phase... - Cure Parkinson's
Johns Hopkins startup Neuraly plans phase 1 Parkinson’s trial with $36M round
Written by
Farooqji
To view profiles and participate in discussions please or .
3 Replies
•
Pre phase I odds of turning into a useful drug something like 1/5000
Hi Iqbal
Any update from resuming Ibogaine? I remember that you were going to resume taking that from mid July.
Please let us know.
Not what you're looking for?
You may also like...
MRI-Focused Ultrasound Undergoing Phase 3 Clinical Trial for Parkinson’s Treatment
New technology that uses MRI-guided focused ultrasound to target areas of the brain affected by...
Dr. Tom Foltynie of Cure Parkinson’s Addresses Bydureon (Exanatide) Phase III Trial.
I know several posts have been made regarding the exanatide trials, but I just stumbled across this...
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...
GOOD NEWS! Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease, says Johns Hopkins Medicine researchers
https://www.news-medical.net/news/20220728/Newly-developed-nanobody-can-get-...
Nilotinib Does Not Show Promise for Benefit in Phase II Nilotinib for Parkinson’s Disease (NILO-PD) Trial
Nilotinib seen to be safe and tolerable, but study strictly excluded those with heart issues or...
Related Posts
has anyone heard of gene therapy to treat pd? i have read where 15 people went thru phase 1 clinical trial and are now working on phase 2.
Phone call w/ Stem Cell Trial- Preclinical- 10 PWP ASAP. Participate in the preclinical to be first to have chance at phase 1 clinical. 
Communication with People Suffering Parkinson’s Disease (PD). Some Observations from Pete-1. A Contribution to World PD Awareness Day
